CSIMarket
 
Morphic Holding inc   (MORF)
Other Ticker:  
 
 
Price: $33.4600 $-1.09 -3.155%
Day's High: $34.68 Week Perf: -5.72 %
Day's Low: $ 33.36 30 Day Perf: -13.43 %
Volume (M): 399 52 Wk High: $ 63.08
Volume (M$): $ 13,347 52 Wk Avg: $40.64
Open: $34.32 52 Wk Low: $19.34



 Market Capitalization (Millions $) 1,418
 Shares Outstanding (Millions) 42
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -152
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 1

Morphic Holding Inc
Morphic Holding Inc. is a technology company that focuses on developing and commercializing shape-shifting user interfaces for electronic devices. The company aims to create adaptive and personalized interfaces that can transform to meet the specific needs and preferences of individual users.

These shape-shifting interfaces, termed morphic interfaces, have the ability to dynamically adjust their appearance, layout, and functionality based on user input or contextual cues. The goal is to provide a more intuitive and efficient user experience across various devices, such as smartphones, tablets, computers, and wearable technology.

Morphic Holding Inc. invests heavily in research and development to continuously improve and expand the capabilities of its morphic interfaces. The company strives to make technology more accessible and inclusive, catering to different age groups, skill levels, and physical abilities.

Overall, Morphic Holding Inc. aims to revolutionize the way people interact with electronic devices by replacing static and rigid interfaces with adaptable and personalized interfaces that enhance user productivity, comfort, and satisfaction.


   Company Address: 35 Gatehouse Drive Waltham 2451 MA
   Company Phone Number: 996-0955   Stock Exchange / Ticker: NASDAQ MORF
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Morphic Holding Inc

Morphic Holding Inc faces challenges with increased shortfall per share in 2023

Morphic Holding Inc, a major pharmaceutical preparations company, recently reported its financial performance for the time-frame ending December 31, 2023. The company experienced a significant increase in its shortfall per share compared to the previous year, with a per share shortfall of $-0.84 as opposed to $-0.62. Additionally, there was a surge in the shortfall from the previous quarter, with the company reporting a per share shortfall of $-0.73.
Despite these concerning figures, the company's revenue remained unchanged at $0.00 million, down from $6.14 million in the same quarter a year prior. Morphic Holding Inc realized a net shortfall of $-40.735 million for the financial period ending in 2023, a marked increase from $-24.377 million the previous year.

Morphic Holding Inc

Morphic Holding Inc Makes Strides in Ulcerative Colitis Treatment at UEG Week 2023

Morphic Holding Inc, a biopharmaceutical company specializing in the development of oral integrin therapies for the treatment of autoimmune and inflammatory diseases, presented positive data for its drug MORF-057 at UEG Week 2023. The Phase 2a data showed promising results in patients with moderate to severe ulcerative colitis, offering hope for improved treatment options in this challenging condition.
In addition to this positive development, Morphic Holding Inc also released its financial results for the third quarter of 2023. The company reported a decrease in its loss per share from $-0.78 to $-0.73 compared to the previous year. Furthermore, the EPS improved from $-0.92 to $-0.73 per share from the previous reporting period. Although the revenue remained unchanged at $0.00 million, this stability is still significant considering the challenges faced by many companies in the current economic climate.

Morphic Holding Inc

Morphic Holding Inc Posts Record Break Deficits in Q2 2023, Yet Investors Remain Hopeful

Morphic Holding Inc Breaks Record Deficits, but Bullish Investors Stay Optimistic
Despite recording a deficit per stock of $-0.92 per share for the fiscal interval ending June 30, 2023, Morphic Holding Inc continues to capture the attention of bullish investors who remain optimistic about its future prospects. The deficit has seen a significant increase from $0.68 per share recorded a year prior and $-0.90 per share from the preceding financial reporting period. Although the revenue remained unchanged at $0.00 million, down from $60.24 million in the corresponding financial reporting period a year prior and sequentially from $0.52 million, the market remains undeterred by these figures.
For the fiscal interval ending June 30, 2023, Morphic Holding Inc logged a net deficit of $-39.013 million, a stark contrast to the net proceeds of $26.841 million recorded in the corresponding financial reporting period a year before. Despite these challenging financials, investors are holding onto their bullish sentiment, anticipating a turnaround in the near future.






 
  Company Estimates
  Revenue Outlook
Morphic Holding inc does not provide revenue guidance.

Earnings Outlook
Morphic Holding inc does not provide earnings estimates.

Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com